Trial Profile
Prospective cross-sectional study assessing periodontal inflammation in renal transplant recipients receiving everolimus or tacrolimus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- 04 Dec 2015 New trial record